Annals of Oncology · 2018 · 21 citations · 0 references
MedicineOncologyPharmacotherapyCancer PharmacologyMolecular OncologyTumor ProgressionCancer ProgressionLung CancerLung Cancer PharmacotherapyDisease-free Survival AssessmentEgfr InhibitionEgfr Mutation TestingErlotinib TherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii ReviewRecist Criteria